Pharma Digest

Criteria of Maintaining Audit and Inspection Readiness in Pharmaceutical Industry

Criteria of Maintaining Audit and Inspection Readiness in Pharmaceutical Industry

To maintain audit and inspection readiness at all times in pharmaceutical industry, following criteria are to be maintained: 1. Clear Communication Channel 2. Document Control and Management 3. Effective Training and Competency Programs 4. Robust Change Control Processes 5. Real-time Monitoring and Data Analytics 6. A Culture of Continuous Improvement ... Read More
Executing Efficient and Effective CSV Audits

Executing Efficient and Effective CSV Audits

Once planning is complete, it’s time to execute the actual CSV audit. Here are some tips for conducting rigorous, value-adding CSV audits: Interview StakeholdersDiscuss in-depth with stakeholders like system owners, quality managers, and end users. This provides insights into how systems are used and any issues. Examine DocumentationThoroughly review all ... Read More
FDA Compliance Guide on Pre-approval Inspections (PAI) for Drugs

FDA Compliance Guide on Pre-approval Inspections (PAI) for Drugs

FDA

Pre-Approval Inspections (PAIs) are one of several significant milestones with an outsized impact on product approval and market entrance in FDA regulated industries. While organizations that have successfully navigated product development before often ingrain PAI readiness into their processes, companies of all sizes routinely need to devote time and energy ... Read More
Computerized System Validation (CSV) Audits

Computerized System Validation (CSV) Audits

Computerised system validation (CSV) is critical in regulated industries like pharmaceuticals, medical devices, and biotech. It ensures that computerised systems are compliant with guidelines and capable of consistently producing high-quality products and data. A key component of the CSV process is CSV auditing. CSV audits examine and evaluate computerised systems ... Read More
Highlights of Recent FDA Guidance on Nitrosamine Drug Substance

Highlights of Recent FDA Guidance on Nitrosamine Drug Substance

For example, FDA Recommended AI Limits for Certain Hypothetical NDSRIs FDA Recommended AI Limits for Certain NDSRIs Related: APIC Guidance on the Risk Assessment for Presence of N-Nitrosamines in APIs
Stability Requirements for Oral Solid Formulations in ANDA

Stability Requirements for Oral Solid Formulations in ANDA

When submitting an ANDA for a generic drug, one of the critical aspects is ensuring the product’s stability. The drug’s stability is a key factor in maintaining its safety, efficacy, and quality over its intended shelf life. Here are some key considerations: Long-term Stability: The generic drug product should retain ... Read More
Good Practices for Research and Development (R&D) Facilities | WHO Guideline

Good Practices for Research and Development (R&D) Facilities | WHO Guideline

WHO

With an ever-increasing awareness of the risks in pharmaceutical production and control and the lifecycle approaches being followed, greater emphasis is being placed on ensuring that the research and development of products are appropriately controlled and documented. Consequently, it is necessary that manufacturers of pharmaceutical products are able to submit ... Read More
WHO GMP Guideline for Excipients Used in Pharmaceutical Products

WHO GMP Guideline for Excipients Used in Pharmaceutical Products

The WHO guideline Good Manufacturing Practices: supplementary guidelines for the manufacture of pharmaceutical excipients, was published in the WHO Technical ReportSeries No 885, 1999. As excipients are sometimes used in large quantities in pharmaceutical dosage forms, and may contain impurities, they can affect the quality of a finished pharmaceutical product. ... Read More
FDA Findings and Remedies on cGMP Violations

FDA Findings and Remedies on cGMP Violations

FDA

The U.S. Food and Drug Administration (FDA) recently inspected a US drug manufacturing facility and identified several significant cGMP violations, resulting in a Warning Letter (#649198). The violations include: Here are five remediation actions that the company should take: Cleaning and Maintenance Procedures: Investigations and Deviations: Production and Process Control ... Read More
Difference Between QbD and DoE

Difference Between QbD and DoE

Quality by Design (QbD) vs Design of Experiments (DoE) (concepts comparison) Definition: Focus: Application: Approach: Read also: Resource Person: Atefe Nasrollahi
Good Laboratory Practice in Microbiology Laboratory

Good Laboratory Practice in Microbiology Laboratory

Good microbiological laboratory practices (GMLP) are designed to protect both workers (i.e., lab staff, non-lab staff and researchers) and research material (i.e., organisms and equipment) in the microbiology laboratory. It consist of activities that depend on several principles: aseptic technique, control of media, control of test strains, operation and control ... Read More